Supraventricular tachycardia caused by nebulised ipratropium bromide.
AUTOR(ES)
O'Driscoll, B R
RESUMO
A 71 year old patient developed a supraventricular tachycardia after the administration of nebulised ipratropium bromide.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=461809Documentos Relacionados
- Bronchial responsiveness to hyperventilation in children with asthma: inhibition by ipratropium bromide.
- Assessment of the clinical usefulness of nebulised ipratropium bromide in patients with chronic airflow limitation.
- Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease.
- Extraction of streptococcal type 12 M protein by cyanogen bromide.
- Dose response of ipratropium bromide assessed by two methods